n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with calpain in 1 studies
| Studies (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Trials (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Recent Studies (post-2010) (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
|---|---|---|---|---|---|
| 88 | 0 | 36 | 7,019 | 25 | 2,422 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatham, JC; Liu, J; Marchase, RB | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and calpain
| Article | Year |
|---|---|
Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.
Topics: Acetylglucosamine; Adenosine Triphosphate; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calpain; Carrier Proteins; Glucosamine; Microfilament Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oximes; Phenylcarbamates; Rats | 2007 |